Home › Funds › Legato Capital Management LLC › KNSA

Legato Capital Management LLC position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

Legato Capital Management LLC reported holding 79,274 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.57% of its reported portfolio and ranking #20 among its reported holdings. Legato Capital Management LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)79.27K sh
Reported value held$5.91M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Legato Capital Management LLC's KNSA position evolved

Legato Capital Management LLC first disclosed a stake in KNSA in Q3 2023 at 66,918 shares (US$1.2M). The position peaked in Q3 2026 at 79,274 shares, worth US$5.9M. Across 13 filings, Legato Capital Management LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 79,274 shares valued at US$5.9M — a reduction of -8,023 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 66.92K $1.16M New
Q4 2023 66.92K $1.17M Hold
Q1 2024 66.92K $1.32M Hold
Q2 2024 66.92K $1.25M Hold
Q3 2024 67.11K $1.68M Hold
Q4 2024 51.38K $1.02M Reduce
Q1 2025 50.76K $1.13M Reduce
Q2 2025 50.64K $1.40M Hold
Q3 2025 57.64K $2.24M Add
Q4 2025 63.14K $2.60M Add
Q1 2026 70.81K $3.41M Add
Q2 2026 87.30K $5.58M Add
Q3 2026 79.27K $5.91M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 51 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has Legato Capital Management LLC held KNSA?

Legato Capital Management LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Legato Capital Management LLC's current position in KNSA?

As of Q3 2026, Legato Capital Management LLC holds 79.27K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $5.91M, representing 0.57% of its reported portfolio and ranking #20.

Has Legato Capital Management LLC been buying or selling KNSA?

In the latest 13F filing (Q3 2026), Legato Capital Management LLC reduced its position in KNSA. The position peaked in Q3 2026 at 79.27K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.